Tag: Sexually Transmitted Diseases: AIDS/HIV
Maraviroc-Containing HIV PrEP Regimens Safe, Well Tolerated
MVC-containing regimens well tolerated compared with TDF-FTC in HIV-uninfected women in U.S.
Rebound Seen Predelivery After HIV Suppression in Pregnancy
6 percent of women with HIV suppression during pregnancy had viral load rebound before delivery
Single Measures of Viral Load May Overestimate HIV Suppression
Overall, 57.3 percent had suppressed load in most recent test; 47.6 percent had durable suppression
APA: Population of Older Adults With HIV Increasing
Guidance to address ageism in HIV care includes targeting older adults with prevention, education
July 2017 Briefing – HIV & AIDS
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for July 2017. This roundup includes...
Penile Microbiome May Be Risk Factor for HIV in Men
Modifying the penile microbiome could potentially reduce HIV acquisition in both men and women
Long-Acting Antiretroviral Injection Safe, Effective for HIV
Cabotegravir + rilpivirine injection every four or eight weeks as effective as daily three-drug oral therapy
Improved Survival With Enhanced Prophylaxis Plus ART in HIV
Enhanced antimicrobial prophylaxis tied to lower mortality at 24, 48 weeks
Worse Outcomes for HIV Kidney Recipients on PI-Based ART
Increased risk of allograft loss, death for HIV-positive patients receiving protease inhibitor ART
June 2017 Briefing – HIV & AIDS
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for June 2017. This roundup includes...
